Virus-associated chronic endometritis: treatment options
- 作者: Tapilskaya N.I.1,2, Tolibova G.K.1,3, Tral T.G.1,2, Savicheva A.M.1,2, Glushakov R.I.2,4,5, Sadikova G.A.1, Budilovskaya O.V.1,2, Krysanova A.A.1,2, Gzgzyan A.M.1,5, Bespalova O.N.1
-
隶属关系:
- Ott Research Institute of Obstetrics, Gynecology and Reproductology
- Saint Petersburg State Pediatric Medical University
- Mechnikov North-Western State Medical University
- Kirov Military Medical Academy
- Saint Petersburg State University
- 期: 卷 24, 编号 5 (2022)
- 页面: 348-354
- 栏目: ORIGINAL ARTICLE
- URL: https://ogarev-online.ru/2079-5831/article/view/107709
- DOI: https://doi.org/10.26442/20795696.2022.5.201693
- ID: 107709
如何引用文章
全文:
详细
Aim. To evaluate the effectiveness of Alloferon (Allokin-alfa®) in the complex treatment of virus-associated chronic endometritis (CE) in patients with infertility, papillomavirus infection (PVI) persisting in the uterine cavity, and recurrent herpes-virus infection localized in the genital area.
Materials and methods. A prospective (n=33) open randomized (2:1) study was conducted to assess the efficacy of Alloferon (Allokin-alfa®) in the complex treatment of CE in patients with infertility, PVI, and recurrent herpes-virus infection, aged 25 to 37 years (median age 31 [29; 32.5] years). All patients received valacyclovir therapy at 500 mg once daily for 30 days from the day of randomization. Patients in the main group (n=21) simultaneously with the start of antiviral therapy received Allokin-alfa® as 9 subcutaneous injections once every two days (one injection every other day). The uterine cavity microbiota of the patients was assessed 3 months after treatment, and histological and immunohistochemical studies of endometrial biopsy specimens were performed.
Results. The microbiological data analysis showed HPV elimination in 71.4% vs 16.7% of patients in the alloferon and control groups, respectively (χ2 – 7.102, p=0.008). Also, in the main group, a significant decrease in the severity of CE (χ2 – 27.586, p<0.001) and p16ink4a protein expression levels (χ2 – 6.17, p=0.013) were observed.
Conclusion. In the treatment of virus-associated CE, the addition of alloferon to virus-suppressive therapy leads to higher rates of HPV elimination from the uterine cavity and significantly reduces the severity of CE.
作者简介
Natalia Tapilskaya
Ott Research Institute of Obstetrics, Gynecology and Reproductology; Saint Petersburg State Pediatric Medical University
编辑信件的主要联系方式.
Email: tapnatalia@yandex.ru
ORCID iD: 0000-0001-5309-0087
D. Sci. (Med.), Prof.
俄罗斯联邦, Saint Petersburg; Saint PetersburgGulrukhsor Tolibova
Ott Research Institute of Obstetrics, Gynecology and Reproductology; Mechnikov North-Western State Medical University
Email: gulyatolibova@yandex.ru
ORCID iD: 0000-0002-6216-6220
D. Sci. (Med.)
俄罗斯联邦, Saint Petersburg; Saint PetersburgTatiana Tral
Ott Research Institute of Obstetrics, Gynecology and Reproductology; Saint Petersburg State Pediatric Medical University
Email: ttg.tral@yandex.ru
ORCID iD: 0000-0001-8948-4811
Cand. Sci. (Med.)
俄罗斯联邦, Saint Petersburg; Saint PetersburgAlevtina Savicheva
Ott Research Institute of Obstetrics, Gynecology and Reproductology; Saint Petersburg State Pediatric Medical University
Email: savitcheva@mail.ru
ORCID iD: 0000-0003-3870-5930
D. Sci. (Med.), Prof.
俄罗斯联邦, Saint Petersburg; Saint PetersburgRuslan Glushakov
Saint Petersburg State Pediatric Medical University; Kirov Military Medical Academy; Saint Petersburg State University
Email: glushakovruslan@gmail.com
ORCID iD: 0000-0002-0161-5977
D. Sci. (Med.)
俄罗斯联邦, Saint Petersburg; Saint Petersburg; Saint PetersburgGavkar Sadikova
Ott Research Institute of Obstetrics, Gynecology and Reproductology
Email: iagmail@ott.ru
Graduate Student
俄罗斯联邦, Saint PetersburgOlga Budilovskaya
Ott Research Institute of Obstetrics, Gynecology and Reproductology; Saint Petersburg State Pediatric Medical University
Email: o.budilovskaya@gmail.com
ORCID iD: 0000-0001-7673-6274
Res. Officer
俄罗斯联邦, Saint Petersburg; Saint PetersburgAnna Krysanova
Ott Research Institute of Obstetrics, Gynecology and Reproductology; Saint Petersburg State Pediatric Medical University
Email: krusanova.anna@mail.ru
Res. Officer
俄罗斯联邦, Saint Petersburg; Saint PetersburgAlexander Gzgzyan
Ott Research Institute of Obstetrics, Gynecology and Reproductology; Saint Petersburg State University
Email: iagmail@ott.ru
ORCID iD: 0000-0003-3917-9493
D. Sci. (Med.)
俄罗斯联邦, Saint Petersburg; Saint PetersburgOlesya Bespalova
Ott Research Institute of Obstetrics, Gynecology and Reproductology
Email: shiggerra@mail.ru
ORCID iD: 0000-0002-6542-5953
D. Sci. (Med.), Prof.
俄罗斯联邦, Saint Petersburg参考
- Isaguliants M, Krasnyak S, Smirnova O, et al. Genetic instability and anti-HPV immune response as drivers of infertility associated with HPV infection. Infect Agent Cancer. 2021;16(1):29. doi: 10.1186/s13027-021-00368-1
- Muscianisi F, De Toni L, Giorato G, et al. Is HPV the novel target in male idiopathic infertility? A systematic review of the literature. Front Endocrinol. 2021;12:643539. doi: 10.3389/fendo.2021.643539
- Yuan S, Qiu Y, Xu Y, Wang H. Human papillomavirus infection and female infertility: a systematic review and meta-analysis. Reprod Biomed Online. 2020;40(2):229-37. doi: 10.1016/j.rbmo.2019.10.019.
- Тапильская Н.И., Объедкова К.В., Крихели И.О., и др. Персистирующая папилломавирусная инфекция в генезе репродуктивных потерь. Перспективы терапии. Медицинский совет. 2021;3:8-17 [Tapilskaya NI, Ob'edkova KV, Krikheli IO, et al. Persistent human papillomavirus infection in the genesis of reproductive losses. Prospects for therapy. Medicinskiy sovet. 2021;3:8-17 (in Russian)]. doi: 10.21518/2079-701X-2021-3-8-17
- Puente E, Alonso L, Laganà AS, et al. Chronic endometritis: old problem, novel insights and future challenges. Int J Fertil Steril. 2020;13(4):250-6. doi: 10.22074/ijfs.2020.5779
- Farsimadan M, Motamedifar M. The effects of human immunodeficiency virus, human papillomavirus, herpes simplex virus-1 and -2, human herpesvirus-6 and -8, cytomegalovirus, and hepatitis B and C virus on female fertility and pregnancy. Br J Biomed Sci. 2021;78(1):1-11. doi: 10.1080/09674845.2020.1803540
- Тапильская Н.И., Будиловская О.В., Крысанова А.А., и др. Микробиота эндометрия женщин с хроническим эндометритом и идиопатическим бесплодием. Акушерство и гинекология. 2020;4:72-81 [Tapilskaya NI, Budilovskaya OV, Krysanova AA, et al. Endometrial microbiota of women with chronic endometritis and idiopathic infertility. Akusherstvo i ginekologiya. 2020;4:72-81 (in Russian)]. doi: 10.18565/aig.2020.4.72-81
- Günther V, Otte SV, Freytag D, et al. Recurrent implantation failure – an overview of current research. Gynecol Endocrinol. 2021;37(7):584-90. doi: 10.1080/09513590.2021.1878136
- Тапильская Н.И. Роль иммунной системы в патогенезе невынашивания беременности. Предпосылки для фармакологической коррекции. Обзоры по клинической фармакологии и лекарственной терапии. 2002;1(2):15-26 [Tapilskaya NI. Rol' immunnoi sistemy v patogeneze nevynashivaniia beremennosti. Predposylki dlia farmakologichekoi korrektsii. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii. 2002;1(2):15-26 (in Russian)].
- Ибишев Х.С., Крахоткин Д.В., Мамедов В.К., Паленый А.И. Эффективность аллоферона в комплексной терапии хронического рецидивирующего папилломавирусного цистита. Урология. 2021;4:35-40 [Ibishev KS, Krakhotkin DV, Mamedov VK, Palenyy AI. The effectiveness of alloferon in the complex therapy of chronic recurrent papillomavirus cystitis. Urologiya. 2021;4:35-40 (in Russian)]. doi: 10.18565/urology.2021.4.35-40
- Толибова Г.Х., Траль Т.Г., Клещев М.А. Эндометриальная дисфункция: алгоритм клинико-морфологического исследования. СПб., 2016 [Tolibova GKh, Tral’ TG, Kleshchev MA. Endometrial'naia disfunktsiia: algoritm kliniko-morfologicheskogo issledovaniia. Saint Petersburg, 2016 (in Russian)].
- Файзуллина Д.И. Эффективность комплексной терапии хронического эндометрита после неудач ЭКО в анамнезе: автореф. дис. … канд. мед. наук. М., 2019 [Faizullina DI. Effektivnost' kompleksnoi terapii khronicheskogo endometrita posle neudach EKO v anamneze: avtoref. dis. … kand. med. nauk. Moscow, 2019 (in Russian)].
- Марченко Л.А., Лушкова И.П. Генитальный герпес и его влияние на репродуктивное здоровье женщины. Качество жизни. Медицина. 2004;3(6):39 [Marchenko LA, Lushkova IP. Genital'nyi gerpes i ego vliianie na reproduktivnoe zdorov'e zhenshchiny. Kachestvo zhizni. Meditsina. 2004;3(6):39 (in Russian)].
- Генитальный герпес. Клинические рекомендации. РОДВК, 2016 [Genital'nyi gerpes. Klinicheskie rekomendatsii. RODVK, 2016 (in Russian)].
- Guidry JT, Scott RS. The interaction between human papillomavirus and other viruses. Virus Res. 2017;231:139-47. doi: 10.1016/j.virusres.2016.11.002
- Тапильская Н.И., Воробцова И.Н., Глушаков Р.И. Спонтанный клиренс вируса папилломы человека в результате супрессивной терапии ациклическими нуклеозидами рецидивирующей герпес-вирусной инфекции, локализованной в области гениталий. Гинекология. 2017;19(3):55-61 [Tapilskaya NI, Vorobtsova IN, Glushakov RI. Spontaneous clearance of the human papilloma virus as a result of suppressive therapy with acyclic nucleosides of a recurrent herpes-viral infection. Gynecology. 2017;19(3):55-61 (in Russian)]. doi: 10.26442/2079-5696_19.3.55-61
- Carbone L, Conforti A, La Marca A, et al. The negative impact of most relevant infections on fertility and assisted reproduction technology. Minerva Obstet Gynecol. 2022;74(1):83-106. doi: 10.23736/S2724-606X.21.04870-3
- Виноградова О.П., Андреева Н.А., Епифанова О.В., Артёмова О.И. Эффективность применения иммунопротивовирусной терапии цервикальных интраэпителиальных неоплазий I степени на фоне папилломавирусной инфекции. Архив акушерства и гинекологии им. В.Ф. Снегирева. 2021;8(3):155-66 [Vinogradova OP, Andreeva NA, Epifanova OV, Artemova OI. Efficacy of immunological antivirus therapy for papillomavirus-associated grade I cervical intraepithelial neoplasia. Snegirev Archives of Obstetrics and Gynecology. 2021;8(3):155-66 (in Russian)]. doi: 10.17816/2313-8726-2021-8-3-155-166
- Липатов И.С., Тезиков Ю.В., Овчинникова М.А. Эффективность профилактической гестационной и перинатальной терапии при частом рецидивирующем герпесе с применением цитокиноподобного пептида на прегравидарном возбуждении. Акушерство и гинекология. 2020;1:94-102 [Lipatov IS, Tezikov YuV, Ovchinnikova MA. Efficiency of gestational and perinatal pathology prevention with a cytokine-like peptide in frequently recurring herpes at the pregravid stage. Akusherstvo i ginekologiya. 2020;1:94-102 (in Russian)]. doi: 10.18565/aig.2020.1.94-10
补充文件
